Evigrade

Tilorone

Other antivirals (local classification)

ATC code: J05AX-TILORONE

Updated · Methodology

Marketing claims without evidence base

The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.

F

COVID-19

Not recommended

The Therapeutics Living Guideline and NIH COVID-19 Treatment Guidelines do not mention tilorone. In 2020–2022 Russia massively prescribed the drug in outpatient COVID-19 care without international evidence support. Agents with established benefit are nirmatrelvir/ritonavir in high-risk outpatients, remdesivir, corticosteroids, and tocilizumab in hospitalised patients.

ICD-10: U07.1 · ICD-11: RA01.0

F

Immune support and respiratory infection care

Not recommended

Tilorone (Amixin, Lavomax) is a Soviet-era interferon inducer prescribed in Russia and the CIS for colds, flu, herpes, and immunity. International clinical guidelines (, , , CDC) do not include the drug; the , , and AEMPS have not approved it. No independent international clinical studies with endpoints on cold duration exist. The drug causes GI disturbances, allergic reactions, and hepatotoxicity has been described. If tilorone was recommended, consider seeking a second opinion.

F

Influenza

Not recommended

International influenza guidelines (, 2018, NG191) do not mention tilorone. Proven antivirals are neuraminidase inhibitors (oseltamivir, zanamivir) and the cap-dependent endonuclease inhibitor baloxavir. Independent RCTs of tilorone have not been published in the Cochrane Library or PubMed outside Russian and Ukrainian sources.

ICD-10: J10-J11 · ICD-11: 1E32

How to read tiers A–F
  • AStrong evidence – first or second line in international guidelines
  • BRecommended in selected cases
  • CStudy data contradict each other
  • DBenefit not proven, no documented harm
  • FDocumented harm, or risk without benefit

Mechanism of action

The manufacturer claims induction of endogenous interferons (alpha, beta, gamma) in intestinal epithelium and lymphocytes. Tilorone was synthesised in the United States in the 1970s as an oral interferon inducer, but clinical trials were discontinued due to lack of clinical efficacy and toxicity signals. Current international sources do not mention tilorone as an antiviral agent.

Safety

Contraindications

  • Hypersensitivity to any component
  • Pregnancy and breastfeeding
  • Age under 7 years

Serious adverse effects

  • Potential ocular toxicity (corneal and retinal deposits) from historical US data; no systematic post-marketing surveillance in Russia

Common adverse effects

  • Per manufacturer label: dyspepsia, brief chills
  • Allergic reactions

Pregnancy: can you take Tilorone?

Contraindicated in pregnancy. Safety data have not been published.

Breastfeeding: can you take Tilorone?

Contraindicated during breastfeeding.

Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.

Practical notes

Russian practice note

Tilorone is widely sold in Russia as Amiksin and Lavomax. It is included in Russian Ministry of Health guidelines for influenza and URI but is not recognised by the international medical community. The drug is not registered as a medicine in the United States, EU, Canada, Australia, or the United Kingdom.

Safety concerns

Early US studies in the 1970s documented tilorone accumulation in cornea and retina, with deposits clinically resembling those from chloroquine. This signal contributed to discontinuation of US development. Systematic surveillance of ocular adverse effects in Amiksin users has not been performed in publicly available Russian sources.

Common myths

Myth: 'Amiksin is a real antiviral, it triggers interferon'. Fact: interferon induction in vitro or in animal models does not translate to clinical efficacy in influenza or URI in humans. Without independent RCTs measuring clinical outcomes (illness duration, complications, hospitalisation), the manufacturer's claims remain marketing statements.

Check interaction with another drug

Opens the checker prefilled with this drug. Pick the second one from your regimen.

Open checker

Summary of a multi-drug list →

Medicine list: everything you take in one place →

Frequently asked

What is Tilorone used for?

Tilorone is evaluated for the following indications with varying evidence strength: Immune support and respiratory infection care (evidence tier F), Herpes simplex (evidence tier F), Common cold (evidence tier F). See the full indication matrix with dosing and citations above on this page.

What are the side effects of Tilorone?

Common side effects of Tilorone (≥ 1 in 100): Per manufacturer label: dyspepsia, brief chills, Allergic reactions. See the Safety section for uncommon and serious reactions.

Is Tilorone safe during pregnancy?

Contraindicated in pregnancy. Safety data have not been published.

Is Tilorone compatible with breastfeeding?

Contraindicated during breastfeeding.

Who should not take Tilorone?

Tilorone is contraindicated in: Hypersensitivity to any component; Pregnancy and breastfeeding; Age under 7 years. Full list in the Safety section.

Amiksin is a real antiviral, it triggers interferon

interferon induction in vitro or in animal models does not translate to clinical efficacy in influenza or URI in humans. Without independent RCTs measuring clinical outcomes (illness duration, complications, hospitalisation), the manufacturer's claims remain marketing statements.

Official sources

Direct links to regulator labels. Open in a new tab.

Other drugs in this group

Umifenovir, Valacyclovir, Vitaglutam, Aciclovir, Brivudine, Famciclovir, Lactoferrin, Atazanavir